Srđan Verstovšek
- Genetics top 0.01%
- Myeloproliferative Neoplasms: Diagnosis and Treatment 681
- Chronic Lymphocytic Leukemia Research 173
- Hematology top 0.01%
- Chronic Myeloid Leukemia Treatments 502
- Acute Myeloid Leukemia Research 363
- Multiple Myeloma Research and Treatments 95
- Rheumatology top 0.02%
- Eosinophilic Disorders and Syndromes 275
- Molecular Biology top 0.2%
- Kruppel-like factors research 165
- Oncology top 0.5%
-
- Acute Lymphoblastic Leukemia research 63
- Co-authors
- Hagop M. KantarjianJörge E. CortesGuillermo Garcia‐ManeroFrancis J. GilesStefan FaderlSusan O’BrienDeborah A. ThomasRuben A. Mesa
- Cited by
- GeneticsHematologyRheumatology
- Journals
- New England Journal of Medicine (3 papers)Nature Medicine (1 paper)The Journal of Experimental Medicine (1 paper)
- Partner nations
- United StatesUnited KingdomItaly
In The Last Decade
Srđan Verstovšek
1.0k papers receiving 29.5k citations
Hit Papers
Peers
Comparison fields: 5 of 143
- Genetics 18.7k
- Hematology 18.6k
- Rheumatology 8.5k
- Molecular Biology 12.1k
- Oncology 4.4k
Countries citing papers authored by Srđan Verstovšek
This map shows the geographic impact of Srđan Verstovšek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Srđan Verstovšek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Srđan Verstovšek more than expected).
Fields of papers citing papers by Srđan Verstovšek
This network shows the impact of papers produced by Srđan Verstovšek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Srđan Verstovšek. The network helps show where Srđan Verstovšek may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Srđan Verstovšek, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 4 | |
| 4 | 2023 | 39 | |
| 5 | 2023 | 24 | |
| 6 | 2023 | 17 | |
| 7 | 2023 | 4 | |
| 8 | 2021 | 29 | |
| 9 | 2021 | 88 | |
| 10 | 2020 | 37 | |
| 11 | 2019 | 85 | |
| 12 | 2015 | 8 | |
| 13 | 2013 | 83 | |
| 14 | 2011 | 83 | |
| 15 | 2011 | 80 | |
| 16 | 2010 | 0 | |
| 17 | 2010 | 227 | |
| 18 | 2008 | 151 | |
| 19 | Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panelbreakdown → | 2007 | 604 |
| 20 | 2003 | 13 |
About Srđan Verstovšek
Srđan Verstovšek is a scholar working on Genetics, Hematology and Rheumatology, having authored 1.1k papers that have together received 30.0k indexed citations. Recurring topics across this work include Myeloproliferative Neoplasms: Diagnosis and Treatment (681 papers), Chronic Myeloid Leukemia Treatments (502 papers), Acute Myeloid Leukemia Research (363 papers), Eosinophilic Disorders and Syndromes (275 papers), Chronic Lymphocytic Leukemia Research (173 papers), Kruppel-like factors research (165 papers), Multiple Myeloma Research and Treatments (95 papers) and Acute Lymphoblastic Leukemia research (63 papers). The work is most often cited by research in Genetics (18.7k citations), Hematology (18.6k citations) and Rheumatology (8.5k citations). Srđan Verstovšek has collaborated with scholars based in United States, United Kingdom and Italy. Frequent co-authors include Hagop M. Kantarjian, Jörge E. Cortes, Guillermo Garcia‐Manero, Francis J. Giles, Stefan Faderl, Susan O’Brien, Deborah A. Thomas, Ruben A. Mesa, Zeev Estrov and Alessandra Ferrajoli. Their work appears in journals such as New England Journal of Medicine, Nature Medicine and The Journal of Experimental Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.